GRK 702:  Biomedical Drug Research

• Subject Area: Basic Research in Biology and Medicine
• Term: from 2001 to 2004
• Project identifier: Deutsche Forschungsgemeinschaft (DFG) - Project number 273289

The research training group "Biomedical Drug Research" at the University of Konstanz represents a novel organisation form of graduate teaching apart from traditional structures that links academic and industrial research. Faculty members from the research-oriented mid-sized pharmaceutical company Byk Gulden Lomberg GmbH, Konstanz, teach 16 graduate students together with university professors. The aim is to provide a direct access to most recent techniques in biochemistry, immunology, pharmacology and toxicology for biologists, biochemists, chemists amd medical interns. The research programme with emphasis on de- and regeneration of tissue, vascular dysfunction, acute and chronic inflammation, pulmonary dysfunction and asthma, and infection disease integrates the mutual industrial and academic interests.

• DFG Programme: Research Training Groups
• Applicant Institution: Universität Konstanz
• Participating Institution: Byk-Gulden Lomberg Chemische Fabrik GmbH
• Spokesperson: Professor Dr. Albrecht Wendel
• Participating Researchers: Dr. Johannes Barsig; Dr. Rolf Beume; Dr. Rainer Boer; Dr. Daniela Bundschuh; Professor Dr. Alexander Bürkle; Sascha Dammeier, Ph.D.; Dr. Manfred Eltze; Privatdozent Dr. Florian Gantner; Dr. Volker Gekeler; Professor Dr. Marcus Groettrup (†); Professor Dr. Thomas Hartung; Dr. Armin Hatzelmann; Dr. Thomas Klein; Professor Dr. Rolf Knippers (†); Professor Dr. Wolfgang Kromer; Professor Dr. Marcel Leist; Dr. Klaus Melchers; Dr. Inge Mühldorfer; Professor Dr. Pierluigi Nicotera; Professor Dr. Heinz-Werner Radtke; Privatdozentin Dr. Jutta Schlepper-Schäfer; Privatdozent Dr. Christian Schudt; Professor Dr. Klaus P. Schäfer; Dr. Wolfram Steinhilber; Professor Dr. Volker Ullrich